Newton BioCapital

Newton BioCapital

A venture capital firm in Belgium that focuses on financing biotech and life science projects.

Newton Biocapital is a venture capital firm in Belgium that focuses on financing biotech and life science projects. Founded 2017 in Brussels Hoofdstedelijk Gewest, Belgium by Alain Parthoens, it invests in early stage ventures and seed. Its portfolio companies include Acticor Biotech, EditForce, Sequana Medical, ChromaCure, Synergia Medical and DIM3. As of March 2020, Newton Biocapital has made seven investments. Their most recent investment was on November 6, 2019, when Acticor Biotech raised €7M. Newton Biocapital has had one exit, which was Sequana Medical. The company has raised a single venture fund, Newton Biocapital i S.A. Pricaf. This fund was announced on January 1, 2017 and raised a total of €82M.

Timeline

2015

Founded

Funded Companies

Company
Industry
Website
Location
Acticor Biotech
1 Result
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Toshiyuki Mori

Partner

Alain Parthoens

Managing Partner and Founder

Els Hubloux

Partner

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Acticor Biotech

ChromaCure

DIM3

EditForce

Sequana Medical

Synergia Medical

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.